(BAMNB) Koninklijke BAM Groep - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000337319
Construction, Infrastructure, Buildings, Maintenance, PPP
Dividends
| Dividend Yield | 4.03% |
| Yield on Cost 5y | 16.56% |
| Yield CAGR 5y | 29.10% |
| Payout Consistency | 67.6% |
| Payout Ratio | 43.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.2% |
| Value at Risk 5%th | 49.2% |
| Relative Tail Risk | -12.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.52 |
| Alpha | 123.59 |
| CAGR/Max DD | 2.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.462 |
| Beta | 0.295 |
| Beta Downside | 0.569 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.24% |
| Mean DD | 9.06% |
| Median DD | 6.72% |
Description: BAMNB Koninklijke BAM Groep January 14, 2026
Koninklijke BAM Groep NV (ticker BAMNB) is a Dutch-based, globally active construction and property group that operates across civil engineering, building, and public-private partnership (PPP) markets.
Through its subsidiaries, BAM delivers a broad portfolio that includes road, rail, bridge, tunnel, cable, sewage and energy infrastructure projects, as well as prefabricated and custom low-rise and mid-rise buildings, student housing, retirement homes, and the Flow-brand wooden homes. The firm also designs, builds, maintains and operates commercial, healthcare, educational, leisure, industrial and airport facilities.
Key recent metrics (FY 2023): revenue €8.1 bn, order backlog €12.5 bn (≈ 155 % of annual revenue), adjusted EBIT margin 5.8 %, and a free-cash-flow conversion of 85 %. The business is sensitive to European infrastructure spending cycles, especially EU-driven green-transition projects and the resurgence of PPP pipelines after the pandemic-induced slowdown. Construction cost inflation and labour shortages remain material risk factors that can compress margins.
For a deeper, data-rich assessment of BAM’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a look.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (262.5m TTM) > 0 and > 6% of Revenue (6% = 564.3m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 9.49pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -0.76% (prev -1.10%; Δ 0.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 158.6m <= Net Income 262.5m (YES >=105%, WARN >=100%) |
| Net Debt (-407.9m) to EBITDA (411.9m) ratio: -0.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (259.7m) change vs 12m ago -5.88% (target <= -2.0% for YES) |
| Gross Margin 13.58% (prev 55.49%; Δ -41.91pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 241.9% (prev 210.1%; Δ 31.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 22.06 (EBITDA TTM 411.9m / Interest Expense TTM 10.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.42
| (A) -0.02 = (Total Current Assets 2.53b - Total Current Liabilities 2.60b) / Total Assets 3.85b |
| (B) 0.03 = Retained Earnings (Balance) 122.4m / Total Assets 3.85b |
| (C) 0.06 = EBIT TTM 229.9m / Avg Total Assets 3.89b |
| (D) 0.04 = Book Value of Equity 122.4m / Total Liabilities 2.96b |
| Total Rating: 0.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.66
| 1. Piotroski 4.0pt |
| 2. FCF Yield 1.68% |
| 3. FCF Margin 0.36% |
| 4. Debt/Equity 0.10 |
| 5. Debt/Ebitda -0.99 |
| 6. ROIC - WACC (= 14.64)% |
| 7. RoE 28.80% |
| 8. Rev. Trend -2.32% |
| 9. EPS Trend 0.12% |
What is the price of BAMNB shares?
As of January 19, 2026, the stock is trading at EUR 9.41 with a total of 660,249 shares traded.
Over the past week, the price has changed by -1.41%, over one month by +2.62%, over three months by +25.89% and over the past year by +131.81%.
Over the past week, the price has changed by -1.41%, over one month by +2.62%, over three months by +25.89% and over the past year by +131.81%.
Is BAMNB a buy, sell or hold?
Koninklijke BAM Groep has no consensus analysts rating.
What are the forecasts/targets for the BAMNB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.4 | -0.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.4 | 53.3% |
BAMNB Fundamental Data Overview January 19, 2026
Market Cap USD = 2.84b (2.44b EUR * 1.1624 EUR.USD)
P/E Trailing = 22.9512
P/E Forward = 11.0742
P/S = 0.3656
P/B = 2.7588
Revenue TTM = 9.41b EUR
EBIT TTM = 229.9m EUR
EBITDA TTM = 411.9m EUR
Long Term Debt = 82.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 10.3m EUR (from shortLongTermDebt, last quarter)
Debt = 92.7m EUR (Calculated: Short Term 10.3m + Long Term 82.4m)
Net Debt = -407.9m EUR (calculated as Total Debt 92.7m - CCE 500.6m)
Enterprise Value = 2.04b EUR (2.44b + Debt 92.7m - CCE 500.6m)
Interest Coverage Ratio = 22.06 (Ebit TTM 229.9m / Interest Expense TTM 10.4m)
EV/FCF = 59.46x (Enterprise Value 2.04b / FCF TTM 34.2m)
FCF Yield = 1.68% (FCF TTM 34.2m / Enterprise Value 2.04b)
FCF Margin = 0.36% (FCF TTM 34.2m / Revenue TTM 9.41b)
Net Margin = 2.79% (Net Income TTM 262.5m / Revenue TTM 9.41b)
Gross Margin = 13.58% ((Revenue TTM 9.41b - Cost of Revenue TTM 8.13b) / Revenue TTM)
Gross Margin QoQ = 6.48% (prev 26.47%)
Tobins Q-Ratio = 0.53 (Enterprise Value 2.04b / Total Assets 3.85b)
Interest Expense / Debt = 7.04% (Interest Expense 6.52m / Debt 92.7m)
Taxrate = 7.67% (5.16m / 67.3m)
NOPAT = 212.3m (EBIT 229.9m * (1 - 7.67%))
Current Ratio = 0.97 (Total Current Assets 2.53b / Total Current Liabilities 2.60b)
Debt / Equity = 0.10 (Debt 92.7m / totalStockholderEquity, last quarter 885.9m)
Debt / EBITDA = -0.99 (Net Debt -407.9m / EBITDA 411.9m)
Debt / FCF = -11.91 (Net Debt -407.9m / FCF TTM 34.2m)
Total Stockholder Equity = 911.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.75% (Net Income 262.5m / Total Assets 3.85b)
RoE = 28.80% (Net Income TTM 262.5m / Total Stockholder Equity 911.6m)
RoCE = 23.13% (EBIT 229.9m / Capital Employed (Equity 911.6m + L.T.Debt 82.4m))
RoIC = 21.62% (NOPAT 212.3m / Invested Capital 981.7m)
WACC = 6.98% (E(2.44b)/V(2.54b) * Re(7.0%) + D(92.7m)/V(2.54b) * Rd(7.04%) * (1-Tc(0.08)))
Discount Rate = 7.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.35%
[DCF Debug] Terminal Value 82.03% ; FCFF base≈34.2m ; Y1≈34.4m ; Y5≈36.8m
Fair Price DCF = 4.68 (EV 806.6m - Net Debt -407.9m = Equity 1.21b / Shares 259.7m; r=6.98% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: 0.12 | EPS CAGR: -22.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: -2.32 | Revenue CAGR: -0.54% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=-0.037 | Revisions Net=+1 | Growth EPS=+15.5% | Growth Revenue=+3.4%
P/E Trailing = 22.9512
P/E Forward = 11.0742
P/S = 0.3656
P/B = 2.7588
Revenue TTM = 9.41b EUR
EBIT TTM = 229.9m EUR
EBITDA TTM = 411.9m EUR
Long Term Debt = 82.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 10.3m EUR (from shortLongTermDebt, last quarter)
Debt = 92.7m EUR (Calculated: Short Term 10.3m + Long Term 82.4m)
Net Debt = -407.9m EUR (calculated as Total Debt 92.7m - CCE 500.6m)
Enterprise Value = 2.04b EUR (2.44b + Debt 92.7m - CCE 500.6m)
Interest Coverage Ratio = 22.06 (Ebit TTM 229.9m / Interest Expense TTM 10.4m)
EV/FCF = 59.46x (Enterprise Value 2.04b / FCF TTM 34.2m)
FCF Yield = 1.68% (FCF TTM 34.2m / Enterprise Value 2.04b)
FCF Margin = 0.36% (FCF TTM 34.2m / Revenue TTM 9.41b)
Net Margin = 2.79% (Net Income TTM 262.5m / Revenue TTM 9.41b)
Gross Margin = 13.58% ((Revenue TTM 9.41b - Cost of Revenue TTM 8.13b) / Revenue TTM)
Gross Margin QoQ = 6.48% (prev 26.47%)
Tobins Q-Ratio = 0.53 (Enterprise Value 2.04b / Total Assets 3.85b)
Interest Expense / Debt = 7.04% (Interest Expense 6.52m / Debt 92.7m)
Taxrate = 7.67% (5.16m / 67.3m)
NOPAT = 212.3m (EBIT 229.9m * (1 - 7.67%))
Current Ratio = 0.97 (Total Current Assets 2.53b / Total Current Liabilities 2.60b)
Debt / Equity = 0.10 (Debt 92.7m / totalStockholderEquity, last quarter 885.9m)
Debt / EBITDA = -0.99 (Net Debt -407.9m / EBITDA 411.9m)
Debt / FCF = -11.91 (Net Debt -407.9m / FCF TTM 34.2m)
Total Stockholder Equity = 911.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.75% (Net Income 262.5m / Total Assets 3.85b)
RoE = 28.80% (Net Income TTM 262.5m / Total Stockholder Equity 911.6m)
RoCE = 23.13% (EBIT 229.9m / Capital Employed (Equity 911.6m + L.T.Debt 82.4m))
RoIC = 21.62% (NOPAT 212.3m / Invested Capital 981.7m)
WACC = 6.98% (E(2.44b)/V(2.54b) * Re(7.0%) + D(92.7m)/V(2.54b) * Rd(7.04%) * (1-Tc(0.08)))
Discount Rate = 7.0% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.35%
[DCF Debug] Terminal Value 82.03% ; FCFF base≈34.2m ; Y1≈34.4m ; Y5≈36.8m
Fair Price DCF = 4.68 (EV 806.6m - Net Debt -407.9m = Equity 1.21b / Shares 259.7m; r=6.98% [WACC]; 5y FCF grow 0.0% → 2.90% )
EPS Correlation: 0.12 | EPS CAGR: -22.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: -2.32 | Revenue CAGR: -0.54% | SUE: 0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=-0.037 | Revisions Net=+1 | Growth EPS=+15.5% | Growth Revenue=+3.4%